| Shift work and the assessment and management of shift work disorder (SWD) KP Wright Jr, RK Bogan, JK Wyatt Sleep medicine reviews 17 (1), 41-54, 2013 | 541 | 2013 |
| Ropinirole decreases periodic leg movements and improves sleep parameters in patients with restless legs syndrome R Allen, PM Becker, R Bogan, M Schmidt, CA Kushida, JM Fry, JS Poceta, ... Sleep 27 (5), 907-914, 2004 | 256 | 2004 |
| Ropinirole in the treatment of patients with restless legs syndrome: a US-based randomized, double-blind, placebo-controlled clinical trial RK Bogan, JM Fry, MH Schmidt, SW Carson, SY Ritchie Mayo Clinic Proceedings 81 (1), 17-27, 2006 | 192 | 2006 |
| The national veteran sleep disorder study: descriptive epidemiology and secular trends, 2000–2010 M Alexander, MA Ray, JR Hébert, SD Youngstedt, H Zhang, SE Steck, ... Sleep 39 (7), 1399-1410, 2016 | 177 | 2016 |
| Rotigotine improves restless legs syndrome: a 6‐month randomized, double‐blind, placebo‐controlled trial in the United States WA Hening, RP Allen, WG Ondo, AS Walters, JW Winkelman, P Becker, ... Movement disorders 25 (11), 1675-1683, 2010 | 122 | 2010 |
| Randomized polysomnography study of gabapentin enacarbil in subjects with restless legs syndrome JW Winkelman, RK Bogan, MH Schmidt, JD Hudson, SE DeRossett, ... Movement disorders 26 (11), 2065-2072, 2011 | 87 | 2011 |
| A multicenter evaluation of oral pressure therapy for the treatment of obstructive sleep apnea IM Colrain, J Black, LC Siegel, RK Bogan, PM Becker, M Farid-Moayer, ... Sleep medicine 14 (9), 830-837, 2013 | 81 | 2013 |
| Long-term maintenance treatment of restless legs syndrome with gabapentin enacarbil: a randomized controlled study RK Bogan, MAC Bornemann, CA Kushida, PV Trân, RW Barrett, ... Mayo Clinic Proceedings 85 (6), 512-521, 2010 | 81 | 2010 |
| Dosing regimen effects of modafinil for improving daytime wakefulness in patients with narcolepsy JRL Schwartz, NT Feldman, RK Bogan, MT Nelson, RJ Hughes Clinical neuropharmacology 26 (5), 252-257, 2003 | 77 | 2003 |
| Effect of oral JZP-110 (ADX-N05) treatment on wakefulness and sleepiness in adults with narcolepsy RK Bogan, N Feldman, HA Emsellem, R Rosenberg, Y Lu, G Bream, ... Sleep Medicine 16 (9), 1102-1108, 2015 | 67 | 2015 |
| Update on the pharmacologic management of narcolepsy: mechanisms of action and clinical implications MJ Thorpy, RK Bogan Sleep medicine 68, 97-109, 2020 | 60 | 2020 |
| Effects of restless legs syndrome (RLS) on sleep RK Bogan Neuropsychiatric disease and treatment 2 (4), 513-519, 2006 | 58 | 2006 |
| Efficacy and safety of calcium, magnesium, potassium, and sodium oxybates (lower-sodium oxybate [LXB]; JZP-258) in a placebo-controlled, double-blind, randomized withdrawal … RK Bogan, MJ Thorpy, Y Dauvilliers, M Partinen, R Del Rio Villegas, ... Sleep 44 (3), zsaa206, 2021 | 56 | 2021 |
| Use of blood biomarkers to screen for obstructive sleep apnea WE Fleming, JEC Holty, RK Bogan, D Hwang, AS Ferouz-Colborn, ... Nature and science of sleep, 159-167, 2018 | 56 | 2018 |
| No effect of 8‐week time in bed restriction on glucose tolerance in older long sleepers MR Zielinski, CE Kline, DF Kripke, RK Bogan, SD Youngstedt Journal of sleep research 17 (4), 412-419, 2008 | 54 | 2008 |
| Weight loss in narcolepsy patients treated with sodium oxybate AM Husain, RK Ristanovic, RK Bogan Sleep medicine 10 (6), 661-663, 2009 | 52 | 2009 |
| Time to response with sodium oxybate for the treatment of excessive daytime sleepiness and cataplexy in patients with narcolepsy RK Bogan, T Roth, J Schwartz, M Miloslavsky Journal of Clinical Sleep Medicine 11 (4), 427-432, 2015 | 51 | 2015 |
| Validation of the self-administered version of the international Restless Legs Syndrome study group severity rating scale–the sIRLS D Sharon, RP Allen, P Martinez-Martin, AS Walters, LF Strambi, B Högl, ... Sleep medicine 54, 94-100, 2019 | 50 | 2019 |
| A phase 3, double-blind, randomized, placebo-controlled study of armodafinil for excessive sleepiness associated with jet lag disorder RP Rosenberg, RK Bogan, JM Tiller, R Yang, JM Youakim, CQ Earl, ... Mayo Clinic Proceedings 85 (7), 630-638, 2010 | 50 | 2010 |
| Safety and efficacy of lower-sodium oxybate in adults with idiopathic hypersomnia: a phase 3, placebo-controlled, double-blind, randomised withdrawal study Y Dauvilliers, I Arnulf, N Foldvary-Schaefer, AM Morse, K Šonka, ... The Lancet Neurology 21 (1), 53-65, 2022 | 48 | 2022 |
